太突然，知名药企公告：董事关平因意外不幸去世！他曾操盘钙尔奇、白加黑

Core Viewpoint - Yuanhe Pharmaceutical announced the unfortunate passing of its director, Mr. Guan Ping, on December 1, 2025, due to an accident, expressing deep condolences and gratitude for his contributions to the company [1][3]. Group 1: Company Information - Mr. Guan Ping held 500,000 shares of Yuanhe Pharmaceutical, representing 0.81% of the company's total equity [3]. - The company and its employees paid high respect and heartfelt thanks to Mr. Guan for his hard work and outstanding contributions during his tenure [3]. Group 2: Industry Background - Mr. Guan Ping was a seasoned professional in the Chinese pharmaceutical industry, recognized as one of the top ten professional managers and pharmaceutical elites, earning the nickname "Prince of OTC" for his significant contributions to the OTC market [5][6]. - His career included key positions at major pharmaceutical companies such as Xi'an Janssen, Lizhu Group, Wyeth, Shijiazhuang Pharmaceutical Group, and Dongsheng Technology, where he played a pivotal role in launching successful products like Calcium D and Bai Jia Hei [5][6][7]. - Mr. Guan's innovative marketing strategies, such as in-store promotions and training for pharmacy staff, significantly boosted sales, exemplified by the increase in sales of Calcium D by nearly 20% in 1998 [6][7].